ncRNA basic information
ncRNA ID:
MI0000077
ncRNA Database:
miRBase
ncRNA Name:
miR-21
ncRNA Type:
miRNA
ncRNA Expression:
down-regulated
ncRNA Method:
RT-qPCR
ncRNA Target Gene:
PDCD4,PTEN, and Bcl-2
ncRNA Pathway:
PI3K-AKT-mTOR pathway
Evidence (ncRNA-drug):
validated
drug basic information
Drug ID:
DB00947 (APRD00654)
Drug Name:
Fulvestrant
Drug Method:
The expression levels of miRNA were determined by Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and those of protein were by Western blot analysis. MTT assay was used to test the drug-resistant phenotype changes in cancer cells via overregulation of miRNAs. Levels of phosphatidylserine on cell surface were quantitatively estimated by using Annexin V-fluorescein isothiocyanate (FITC) and Propidium Iodide (PI) apoptosis detection kit.
Drug Response:
sensitive
Cancer basic information
Cancer:
breast cancer
Tissue/Cell:
cell line (MCF-7)
Other information
Title:
Silencing of MicroRNA-21 confers the sensitivity to tamoxifen and fulvestrant by enhancing autophagic cell death through inhibition of the PI3K-AKT-mTOR pathway in breast cancer cells.
Journal:
Biomed Pharmacother
Published:
2016
PubMed ID:
26796263